Abstract:Objective To investigate the effect of intracavitary interventional therapy instrument on cytokines in patients with pelvic inflammatory mass. Methods A total of 130 patients with pelvic inflammatory mass admitted to the Department of Gynecology, Cangzhou People’s Hospital of Hebei Province from October 2018 to June 2020 were selected as the research objects, according to the random number table method, they were divided into medication group and treatment instrument group, with 65 ceses in each group. The medication group was treated with Metronidazole combined with Doxycycline, while the treatment instrument group was treated with luminal interventional therapy instrument. The levels of cytokines (granulocyte-macrophage colony-stimulating factor [GM-CSF], C-reactive protein [CRP], tumor necrosis factor-α [TNF-α], and interleukin-6 [IL-6]), hemorheology, pelvic mass diameter, and pain degree were observed before and after treatment, the clinical efficacy and adverse reactions of the two groups were statistically analyzed. Results After treatment, the levels of GM-CSF, CRP, TNF-α, and IL-6 in the two groups were lower than those before treatment, and the study group was lower than the control group, and the differences were statistically significant (P < 0.05). After treatment, the hemorheological indexes of the two groups were lower than those before treatment, and the hemorheological indexes of the study group were lower than those of the control group, and the differences were statistically significant (P < 0.05). After treatment, the pelvic mass diameter and visual analogue scales score of the two groups were lower than those before treatment, and the study group was lower than the control group, and the differences were statistically significant (P < 0.05). After treatment, the clinical effect of the therapeutic apparatus group was better than that of the drug group, and the difference was statistically significant (P < 0.05). There was no significant difference in adverse reactions between the two groups (P > 0.05). Conclusion The treatment of patients with pelvic inflammatory mass by cavity interventional therapy device is effective and can reduce cytokines, which is worthy of clinical promotion.